Empowering Postmenopausal Women: Osteoboost Delivers Astonishing Results in Bone Density Treatment

Illustrative image of bone structure representing bone health

Bone Health Technologies is making waves with its novel treatment, Osteoboost. At Endo 2023, the company presented a study showing that Osteoboost is an exceptionally promising intervention for postmenopausal loss of bone density and strength.

The double-blinded, sham-controlled study enrolled 126 postmenopausal women with low bone mass. Those who used Osteoboost saw an 82% reduction in bone strength loss and an 85% reduction in loss of bone density.

Laura Yecies, CEO of Bone Health Technologies, emphasized that the results provide a long-awaited non-pharmacological option for the 53 million Americans suffering from osteopenia.

With its wearable design, Osteoboost delivers targeted vibration to the lumbar spine and hips. It represents a breakthrough in the industry, with no serious adverse effects reported.

Bone Health Technologies has achieved a remarkable milestone, and Osteoboost is poised to revolutionize the bone health industry.


Leave a Reply

Your email address will not be published. Required fields are marked *